Correlation Engine 2.0
Clear Search sequence regions

  • diagnosis (2)
  • help (1)
  • humans (1)
  • lung disease (8)
  • patients (3)
  • Sizes of these terms reflect their relevance to your search.

    Interstitial lung disease (ILD) complicates connective tissue disease (CTD) with variable incidence and is a leading cause of death in these patients. To improve CTD-ILD outcomes, early recognition and management of ILD is critical. Blood-based and radiologic biomarkers that assist in the diagnosis CTD-ILD have long been studied. Recent studies, including -omic investigations, have also begun to identify biomarkers that may help prognosticate such patients. This review provides an overview of clinically relevant biomarkers in patients with CTD-ILD, highlighting recent advances to assist in the diagnosis and prognostication of CTD-ILD. Published by Elsevier Inc.


    Janelle Vu Pugashetti, Dinesh Khanna, Ella A Kazerooni, Justin Oldham. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease. Immunology and allergy clinics of North America. 2023 May;43(2):411-433

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37055096

    View Full Text